The potential future burden of COVID-19 is determined by the level of susceptibility of the population to infection. The protective effect provided by those previously infected diminishes over several months, while individuals with mixed immunity have the highest degree and persistence of protection. This study aimed to clarify the vaccination status of COVID-19 patients with hypertension and to analyze the characteristics and risk factors of non-vaccinated patients to protect this vulnerable population in the future. The study ultimately enrolled 4576 hypertensive patients with Omicron infection from April 6, 2022, to May 15, 2022. Among them, 3556 patients (77.7%) had received at least one dose of vaccine, and 2058 patients (45.0%) received a booster dose. In the multivariate logistic analysis, male (OR 1.328, 95% CI 1.138–1.550, p
CITATION STYLE
Zhu, K., Ma, S., Chen, H., Xie, J., Huang, D., Ma, G., & Huang, Y. (2023). Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China. Human Vaccines and Immunotherapeutics, 19(2). https://doi.org/10.1080/21645515.2023.2253599
Mendeley helps you to discover research relevant for your work.